Camp4 Therapeutics Corp 10-K filing
Filed 2026-03-05 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001736730-26-000016
- Form type
- 10-K
- CIK
- 0001736730
- Primary document
- https://www.sec.gov/Archives/edgar/data/1736730/000173673026000016/camp-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Camp4 Therapeutics Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $3.5M | - | - |
| Operating Income | $-52.6M | - | - |
| Net Income | $-80.4M | - | - |
| Eps Basic | -2.65 | - | - |
| Eps Diluted | -2.65 | - | - |
| Cash And Equivalents | $109.5M | - | - |
| Total Assets | $117.8M | - | - |
| Total Liabilities | $70.1M | - | - |
| Shareholders Equity | $47.7M | - | - |
| Operating Cash Flow | $-29.6M | - | - |
| Capital Expenditures | $279,000 | - | - |